ORAGENICS, INC. Notes Assumed
ORAGENICS, INC. (OGEN) reported Notes Assumed of $708.93 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NotesAssumed1 · last filed 2025-03-14
- ORAGENICS, INC. notes assumed for the quarter ending 2024-12-31 was $71.96K.
- ORAGENICS, INC. notes assumed for the quarter ending 2023-12-31 was $0.00.
- ORAGENICS, INC. notes assumed for the quarter ending 2022-12-31 was $0.00.
- ORAGENICS, INC. notes assumed for the quarter ending 2021-12-31 was $0.00.
- ORAGENICS, INC. notes assumed for fiscal 2024 was $708.93K, a 16.01% increase from fiscal 2023.
- ORAGENICS, INC. notes assumed for fiscal 2023 was $611.11K, a 15.65% increase from fiscal 2022.
- ORAGENICS, INC. notes assumed for fiscal 2022 was $528.43K, a 11.95% decline from fiscal 2021.
- ORAGENICS, INC. notes assumed for fiscal 2021 was $600.17K, a 45.04% increase from fiscal 2020.
| Period end | Notes Assumed 3 month | Notes Assumed 6 month | Notes Assumed 9 month | Notes Assumed 12 month |
|---|---|---|---|---|
| 2024-12-31 | $71.96K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $708.93K 10-K · filed 2025-03-14 | ||
| 2024-09-30 | $636.97K 10-Q · filed 2024-11-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $611.11K 10-K · filed 2025-03-14 | ||
| 2023-09-30 | $611.11K 10-Q · filed 2024-11-13 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $528.43K 10-K · filed 2024-03-29 | ||
| 2022-09-30 | $528.43K 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17 | $600.17K 10-K · filed 2023-04-17 | ||
| 2021-09-30 | $600.17K 10-Q/A · filed 2023-04-14 | |||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-29 | $413.78K 10-K/A · filed 2022-07-29 | ||
| 2020-09-30 | $413.78K 10-Q · filed 2020-11-10 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $254.89K derived: sum of 2 quarters · filed 2021-03-01 | $254.89K derived: sum of 3 quarters · filed 2021-03-01 | $272.58K 10-K · filed 2021-03-01 |
| 2019-09-30 | $254.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $254.89K derived: sum of 2 quarters · filed 2020-11-10 | $272.58K 10-Q · filed 2020-11-10 | $272.58K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $17.69K 10-Q · filed 2020-08-14 | $17.69K derived: sum of 3 quarters · filed 2020-08-14 | $233.26K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $17.69K 10-Q · filed 2020-05-15 | $17.69K derived: sum of 2 quarters · filed 2020-05-15 | $233.26K derived: sum of 3 quarters · filed 2020-05-15 | $233.26K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | $215.57K derived: sum of 2 quarters · filed 2020-03-04 | $215.57K derived: sum of 3 quarters · filed 2020-03-04 | $244.49K 10-K · filed 2020-03-04 |
| 2018-09-30 | $215.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $215.57K derived: sum of 2 quarters · filed 2019-11-14 | $244.49K 10-Q · filed 2019-11-14 | $244.49K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $28.91K 10-Q · filed 2019-08-14 | $28.91K derived: sum of 3 quarters · filed 2019-08-14 | $168.98K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $28.91K 10-Q · filed 2019-05-13 | $28.91K derived: sum of 2 quarters · filed 2019-05-13 | $168.98K derived: sum of 3 quarters · filed 2019-05-13 | $168.98K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $140.06K derived: sum of 2 quarters · filed 2019-03-29 | $140.06K derived: sum of 3 quarters · filed 2019-03-29 | $172.05K 10-K · filed 2019-03-29 |
| 2017-09-30 | $140.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $140.06K derived: sum of 2 quarters · filed 2018-11-13 | $172.05K 10-Q · filed 2018-11-13 | $172.05K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $31.98K 10-Q · filed 2018-08-13 | $31.98K derived: sum of 3 quarters · filed 2018-08-13 | $143.72K derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $31.98K 10-Q · filed 2018-05-15 | $31.98K derived: sum of 2 quarters · filed 2018-05-15 | $143.72K derived: sum of 3 quarters · filed 2018-05-15 | $143.72K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $111.73K derived: sum of 2 quarters · filed 2018-02-16 | $111.73K derived: sum of 3 quarters · filed 2018-02-16 | $161.13K 10-K · filed 2018-02-16 |
| 2016-09-30 | $111.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $111.73K derived: sum of 2 quarters · filed 2017-10-31 | $161.13K 10-Q · filed 2017-10-31 | $161.13K derived: sum of 4 quarters · filed 2017-10-31 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $49.40K 10-Q · filed 2017-08-14 | $49.40K derived: sum of 3 quarters · filed 2017-08-14 | |
| 2016-03-31 | $49.40K 10-Q · filed 2017-05-15 | $49.40K derived: sum of 2 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $158.46K 10-K · filed 2017-02-27 | ||
| 2015-09-30 | $158.46K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |